GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Alignment Healthcare Inc (NAS:ALHC) » Definitions » Peter Lynch Fair Value

ALHC (Alignment Healthcare) Peter Lynch Fair Value : N/A (As of May. 08, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Alignment Healthcare Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for Alignment Healthcare's Peter Lynch Fair Value or its related term are showing as below:



ALHC's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Healthcare Plans industry.
Industry Median: 0.89
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Alignment Healthcare Peter Lynch Fair Value Historical Data

The historical data trend for Alignment Healthcare's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alignment Healthcare Peter Lynch Fair Value Chart

Alignment Healthcare Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Peter Lynch Fair Value
Get a 7-Day Free Trial - - - - -

Alignment Healthcare Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Alignment Healthcare's Peter Lynch Fair Value

For the Healthcare Plans subindustry, Alignment Healthcare's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alignment Healthcare's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Alignment Healthcare's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Alignment Healthcare's Price-to-Peter-Lynch-Fair-Value falls into.


;
;

Alignment Healthcare Peter Lynch Fair Value Calculation

Alignment Healthcare's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *-0.657
=N/A

Alignment Healthcare's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was $-0.66.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Alignment Healthcare  (NAS:ALHC) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

Alignment Healthcare's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=15.52/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alignment Healthcare Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Alignment Healthcare's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Alignment Healthcare Business Description

Traded in Other Exchanges
N/A
Address
1100 W. Town & Country Road, Suite 1600, Orange, CA, USA, 92868
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Executives
Dawn Christine Maroney officer: President, Markets C/O ALIGNMENT HEALTHCARE, INC., 1100 W. TOWN & COUNTRY ROAD, SUITE 1600, ORANGE CA 92868
John E Kao director, officer: Chief Executive Officer
Christopher J Joyce officer: Chief Legal and Admin. Officer C/O ALLIANCE ENTERTAINMENT CORP, 110 EAST 59TH STREET 18TH FLOOR, NEW YORK NY 10022
Robert L. Scavo officer: Chief Information Officer C/O ALIGNMENT HEALTHCARE, INC., 1100 W. TOWN AND COUNTRY ROAD, SUITE 160, ORANGE CA 92868
Hakan Kardes officer: Chief Technology Officer C/O ALIGNMENT HEALTHCARE, INC., 1100 W. TOWN AND COUNTRY ROAD, SUITE 160, ORANGE CA 92868
Robert Thomas Freeman officer: Chief Financial Officer C/O ALIGNMENT HEALTHCARE, INC., 1100 W. TOWN & COUNTRY ROAD, SUITE 1600, ORANGE CA 92868
Hyong Kim officer: Chief Medical Officer C/O ALIGNMENT HEALTHCARE, INC., 1100 W TOWN AND COUNTRY ROAD, SUITE 1600, ORANGE CA 92868
Joseph S Konowiecki director 5995 PLAZA DR, CYPRESS CA 90630
Jeffrey H Margolis director 567 SAN NICHOLAS DRIVE, SUITE 360, NEWPORT BEACH CA 92660
Melinda Michele Kimbro officer: Chief People Officer 6155 EL CAMINO REAL, CARLSBAD CA 92009
Dinesh M. Kumar officer: Chief Health Officer C/O ALIGNMENT HEALTHCARE, INC., 1100 W. TOWN & COUNTRY ROAD, SUITE 1600, ORANGE CA 92868
Richard A. Cross officer: SVP, General Counsel C/O ALIGNMENT HEALTHCARE, INC., 1100 W. TOWN AND COUNTRY ROAD, STE. 1600, ORANGE CA 92868
Warburg Pincus Llc director, 10 percent owner 450 LEXINGTON AVENUE, NEW YORK NY 10017
General Atlantic (aln Hlth), L.p. director, 10 percent owner C/O GENERAL ATLANTIC SERVICE COMPANY, LP, 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055
General Atlantic, L.p. director, 10 percent owner 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055